Visual improvement at end of treatment, as defined by two or more Snellen lines · participants with acute CME (< 4 months) following cataract surgery
It is very uncertain whether NSAID changes visual improvement at end of treatment, as defined by two or more… compared with placebo or active control (very low certainty).
1 finding from 1 review
Improvement in central macular thickness on OCT · participants with chronic CME (≥ 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improved contrast sensitivity · participants with chronic CME (≥ 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · participants with chronic CME (≥ 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visual improvement at end of treatment, as defined by two or more Snellen lines · participants with acute or chronic CME following cataract surgery
It is very uncertain whether NSAID changes visual improvement at end of treatment, as defined by two or more… compared with active control (very low certainty).
1 finding from 1 review
Persistence of visual improvement one month after discontinuation of treatment · participants with acute or chronic CME following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in leakage on FFA Â · participants with acute or chronic CME following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in central macular thickness on OCT · participants with acute or chronic CME following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improved contrast sensitivity · participants with acute or chronic CME following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · participants with acute or chronic CME following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Persistence of visual improvement one month after discontinuation of treatment · participants with acute CME (< 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in leakage on FFA Â · participants with acute CME (< 4 months) following cataract surgery
It is very uncertain whether NSAID changes improvement in leakage on FFA Â compared with placebo or active control (very low certainty).
1 finding from 1 review
Improvement in central macular thickness on OCT · participants with acute CME (< 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improved contrast sensitivity · participants with acute CME (< 4 months) following cataract surgery
It is very uncertain whether NSAID changes improved contrast sensitivity  compared with placebo or active control (very low certainty).
1 finding from 1 review
QoL · participants with acute CME (< 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visual improvement at end of treatment, as defined by two or more Snellen lines · participants with chronic CME (≥ 4 months) following cataract surgery
It is very uncertain whether NSAID changes visual improvement at end of treatment, as defined by two or more… compared with placebo (very low certainty).
1 finding from 1 review
Persistence of visual improvement one month after discontinuation of treatment · participants with chronic CME (≥ 4 months) following cataract surgery
It is very uncertain whether NSAID changes persistence of visual improvement one month after discontinuation of… compared with placebo (very low certainty).
1 finding from 1 review
Improvement in leakage on FFA Â · participants with chronic CME (≥ 4 months) following cataract surgery
It is very uncertain whether NSAID changes improvement in leakage on FFA Â compared with placebo (very low certainty).
1 finding from 1 review